Accueil
Bourse
Actions Paris

Consensus des Analystes Biomerieux

Cotation du 19/10/2021 à 17h35 Biomerieux +2,49% 102,850€

Objectif de cours au 20/10/2021

113,096 €
Potentiel de +10%
cours actuel 102,850€

Note médiane des 12 analystes

2,4
5 Vendre 4 Alléger 3 Conserver 2 Renforcer 1 Acheter

Evolution des recommandations

Recommandations 20/10/2020 20/01/2021 20/04/2021 20/07/2021 20/10/2021
Acheter 1 3 3 3 4
Renforcer - 1 3 3 2
Conserver 8 6 3 4 3
Alléger 1 3 3 2 3
Vendre 2 1 1 - -
Nb d'analystes 12 14 13 12 12
Note Médiane 3,25 2,86 2,69 2,42 2,42
Historique des objectifs 114,766€ 125,550€ 121,507€ 111,250€ 113,095€

Prévisions

2020 2021 2022
Chiffre d'affaires 3 118,20 3 164,84 3 164,17
EBITDA 823,50 861,61 769,60
EBIT 595,10 620,53 547,17
Résultat Net 404,40 463,72 409,83
Flux de trésorerie disponible 305,30 376,07 384,85
Dette nette 92,10 -181,74 -460,36
PER 3,68 3,98 3,49
Copyright ©2021, S&P Global Market Intelligence. Reproduction of CIQ Estimates in any form is prohibited except with the prior written permission of S&P Global Market Intelligence. CIQ Estimates are not investment advice and a reference to a particular investment or security, a credit rating or any observation concerning a security or investment provided in CIQ Estimates is not a recommendation to buy, sell or hold such investment or security or make any other investment decisions. S&P Global Market Intelligence, its affiliates and their third-party providers (together, “S&P Global”) do not guarantee the accuracy, adequacy, completeness or availability of any information and are not responsible for any errors or omissions, regardless of the cause or for the results obtained from the use of such information. S&P GLOBAL DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall S&P Global be liable for any direct, indirect, special or consequential damages, costs, expenses, legal fees, or losses (including lost income or lost profit and opportunity costs) in connection with subscriber’s or others’ use of CIQ Estimates.